This message was sent to ##Email##
|
|
|
|
|
Oncology Nurse Advisor
Oncology care providers should develop interventions that remind and encourage them to have physical activity communications with their patients who have early-stage cancer, concluded a study published online ahead of print in the journal Cancer.
Regular physical activity reduces cancer-related fatigue, maintains quality of life and physical function and improves overall prognosis and survival for patients with cancer. However, communications regarding physical activity vary among oncology care providers.
READ MORE
11 a.m. - 12 p.m. EST, Nov. 23
Hosted by the American Cancer Society in collaboration with the National Accreditation Program for Breast Centers
Webinar topics:
Screening recommendations for normal and high-risk populations
Evolution of imaging modalities
Understanding imaging modalities
Resources for patients and providers
Click here to register online.
CoC
The Default Completeness and Overuse Report for 2013 Diagnoses submitted during the 2015 call for data have been released. This report gives CoC-accredited programs information about the completeness of required data items. Site specific reports are available for: Breast, Colon, Rectum, Stomach, Esophagus and EG Junction, Lung, Cervical, Endometrium and Ovary. This report is available under National Cancer Data Base Data Transmission in your CoC Datalinks Activity Menu.
READ MORE
Reuters
Use of a blood test to detect prostate cancer fell after a U.S. government-back panel advised against using it, researchers found.
"I'm hoping that men are being allowed to make a choice and this decline reflects the fact that they prefer not to be screened," said study author Dr. Otis Brawley, who is chief medical officer for the American Cancer Society in Atlanta.
READ MORE
Georgia Institute of Technology via Medical Xpress
Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer. Using advanced liquid chromatography and mass spectrometry techniques coupled with machine learning computer algorithms, researchers have identified 16 metabolite compounds that provided unprecedented accuracy in distinguishing 46 women with early-stage ovarian cancer from a control group of 49 women who did not have the disease.
READ MORE
PRODUCT SHOWCASE
 |
|
Brighton “Power of Pink” Legacy Bracelets and Legacy Bangles Support the NCBC Navigator Program when purchased through our website by November 15. To learn more about breast patient navigation and how to become certified, join us at NCoBC 2016 in Las Vegas, April 9-13, 2016.
|
|
Oncology Nurse Advisor
Only 1 in 5 U.S. patients with pancreatic cancer receive a widely available, inexpensive blood test at diagnosis that can predict whether they are likely to have a better or worse outcome than average and guide treatment accordingly. People who test positive for elevated levels of a particular tumor marker tend to do worse than others, but if they are candidates for surgery and have chemotherapy before their surgery, this personalized treatment sequence eliminates the elevated biomarker's negative effect, researchers found.
READ MORE
GenomeWeb
A public-private team from the U.S. and U.K. has successfully used exome and targeted amplicon sequencing of tissue biopsies and circulating tumor DNA to characterize the genomic architecture of a breast cancer patient's tumor and track its clonal evolution over time in response to various therapies.
READ MORE
ACS
It is not too late! You may purchase the Webcast packages to view the sessions you were not able to attend at Clinical Congress. Webcast sessions are available on your computer, tablet or mobile device anytime, anywhere. Maximize your learning opportunities and earn CME Credit and Self-Assessment Credit when it's convenient for you. Click here to see more.
Pharmaceutical Processing
The National Institute for Health and Care Excellence (NICE) recently published final draft guidance rejecting the routine use of Roche's Kadcyla (trastuzumab emtansine) on the NHS because the price of the breast cancer therapy "remains too high." The agency issued similar guidance in 2014.
READ MORE
Medscape
It is becoming more and more difficult to decide which treatment schedule to give premenopausal women with estrogen receptor-positive breast cancer following the results from the TEXT and SOFT trials," said Vivianne Tjan-Heijnen, M.D., Ph.D., professor in the department of medical oncology at Maastricht University Medical Centre in Maastricht, The Netherlands. The Tamoxifen and Exemestane Trial (TEXT) and the Suppression of Ovarian Function Trial (SOFT) raised a number of questions about the value of ovarian function suppression and the role of adjuvant aromatase inhibitors in these patients.
READ MORE
Lawrence Livermore National Laboratory via Medical Xpress
Scientists from Lawrence Livermore National Laboratory in collaboration with researchers from University of California campuses at Merced and Davis have found that a secreted protein predominantly expressed in bone inhibits prostate cancer metastasis to bone.
READ MORE
ACS
Follow the CoC (@COC_ACS) and the NAPBC (@NAPBC_ACS) on Twitter. Make sure you also like the NAPBC Facebook page.
READ MORE
Medscape
Recently, Anil Potti, M.D., a former star cancer researcher at Duke University, was found by federal investigators to have "engaged in research misconduct" by including "false research data" in multiple published studies and other documents. He received a five-year ban from federal grant funding as punishment.
However, the research in the published studies was undertaken by a team of investigators at Duke, including other clinicians, statisticians and scientists. Various findings led, in turn, to large clinical trials that involved hundreds of patients and subsequent collaboration with other researchers. Is it fair that only one person should take all the blame?
READ MORE
|
Missed last week's issue? See which articles your colleagues read most.
|
|
Don't be left behind. Click here to see what else you missed.
|
|
|
|
|
|
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
